Cherry Creek Investment Advisors Inc. Makes New $1.36 Million Investment in VanEck Pharmaceutical ETF $PPH

Cherry Creek Investment Advisors Inc. bought a new stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 13,129 shares of the company’s stock, valued at approximately $1,355,000. Cherry Creek Investment Advisors Inc. owned 0.11% of VanEck Pharmaceutical ETF as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently made changes to their positions in the company. IFP Advisors Inc increased its position in VanEck Pharmaceutical ETF by 53.7% during the 3rd quarter. IFP Advisors Inc now owns 438 shares of the company’s stock worth $40,000 after purchasing an additional 153 shares in the last quarter. Advisory Services Network LLC purchased a new position in VanEck Pharmaceutical ETF in the third quarter valued at approximately $41,000. PNC Financial Services Group Inc. raised its holdings in VanEck Pharmaceutical ETF by 305.6% in the third quarter. PNC Financial Services Group Inc. now owns 1,014 shares of the company’s stock valued at $92,000 after buying an additional 764 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new position in VanEck Pharmaceutical ETF during the third quarter valued at approximately $290,000. Finally, Jones Financial Companies Lllp lifted its position in VanEck Pharmaceutical ETF by 11.2% during the third quarter. Jones Financial Companies Lllp now owns 3,603 shares of the company’s stock valued at $313,000 after buying an additional 363 shares in the last quarter.

VanEck Pharmaceutical ETF Price Performance

VanEck Pharmaceutical ETF stock opened at $103.88 on Wednesday. VanEck Pharmaceutical ETF has a 12-month low of $77.67 and a 12-month high of $112.58. The company has a market capitalization of $1.15 billion, a price-to-earnings ratio of 20.21 and a beta of 0.54. The firm’s fifty day moving average price is $106.97 and its 200 day moving average price is $100.77.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.